Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo
1 other identifier
observational
18,901
1 country
1
Brief Summary
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2020
CompletedFebruary 15, 2024
February 1, 2024
1 month
May 22, 2020
February 14, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Prevalence of antibodies against SARS-CoV-2 through serological testing
IgM and IgG antibodies against SARS-CoV-2
1 month
Frequency of participants with a positive RT-PCR test result for SARS-CoV-2
Positive RT-PCR test result for SARS-CoV-2
1 month
Study Arms (8)
HC-USP
Home contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo
CORAS
Refugees living in the city of São Paulo
Hemocenter
Blood Donors of the Pró-Sangue Hemocenter Foundation of São Paulo
CPP - Butantan Penitentiary Progression Center
Participants of the CPP - Butantan Penitentiary Progression Center
CHSP - Penitentiary System Hospital Center
Participants of the CHSP - Penitentiary System Hospital Center
SABE (Health, Wellness and Aging)
Participants of the SABE Project (Health, Wellness and Aging)
ILPI - Long-Term Care Institution for the Elderly
Residents of the Long-Term Care Institution for the Elderly of Botucatu
ICR-USP - Children's Institute of HCFMUSP
Home contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP
Interventions
IgM and IgG for SARS-CoV-2
PCR for SARS-CoV-2
PCR for SARS-CoV-2
Eligibility Criteria
* Home contacts of health professionals at the Hospital das Clínicas of the Medical School of USP diagnosed with COVID-19; * Refugees living in the city of São Paulo - CORAS-BR Project; * Blood Donors of the Fundação Pró-Sangue Hemocentro de São Paulo * Butantan Penitentiary Progression Center participants; * Penitentiary System Hospital Center (CHSP) participants; * SABE Project - Cohort of the Elderly in the city of São Paulo and their home contacts; * Residents of the Long Term Care Institution (ILPI) of Botucatu; * Home contacts of children and adolescents with a positive diagnosis for COVID-19, attended at Instituto da Criança, HCFMUSP.
You may qualify if:
- All potential volunteers invited to participate in the study.
You may not qualify if:
- All potential eligible participants, but who do not show interest in participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Avenida Vital Brasil 1500
São Paulo, 05503-900, Brazil
Biospecimen
Nasopharyngeal Swab, Oropharyngeal Swab and Blood Samples
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alexander R Precioso, MD, PhD
Instituto butantan
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2020
First Posted
May 29, 2020
Study Start
June 1, 2020
Primary Completion
July 15, 2020
Study Completion
July 30, 2020
Last Updated
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share